91% 的静脉溃疡患者在接受VenoValve 手术一年后病情有所改善或完全愈合。 91% of venous ulcer patients show improvement or complete healing at one year post-VenoValve surgery.

91% 的静脉溃疡患者在接受 VenoValve 手术一年后症状改善或完全愈合，持续时间为一年或一年以下的溃疡 100% 可完全愈合，持续时间超过一年的溃疡 89% 可愈合或改善。 91% of venous ulcer patients show improvement or complete healing at one year post-VenoValve surgery, with 100% of ulcers lasting one year or less fully healing, and 89% of those lasting over a year either healing or improving. 静脉疾病治疗领域的领先者 enVVeno Medical Corp 在血管外科学会年会上公布了这些积极的中期数据。 enVVeno Medical Corp, a leader in venous disease treatment, presents these positive interim data at the Society for Vascular Surgery's annual meeting. 该公司计划于 2024 年第四季度申请 VenoValve FDA 批准。 The company plans to file for VenoValve FDA approval in Q4 2024.